Project Details
Description
PIPF-016 entitled "A Randomized, Double-Bline, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/11 → 5/31/14 |
Funding
- INTERMUNE PHARM INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.